Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol.
Taku NakagawaMasahide OkiMitsuaki YagiYoshihito KogureMasahiro SekimizuAkiko M SaitoKenji OgawaYoshikazu InouePublished in: BMJ open respiratory research (2019)
This trial was approved by the National Hospital Organisation Review Board for Clinical Trials (Headquarters). The results of this study will be reported at a society meeting or published in a peer-review journal.
Keyphrases
- study protocol
- clinical trial
- open label
- randomized controlled trial
- phase ii
- phase iii
- mycobacterium tuberculosis
- double blind
- helicobacter pylori
- phase ii study
- placebo controlled
- physical activity
- healthcare
- quality improvement
- high intensity
- emergency department
- radiation therapy
- combination therapy
- electronic health record
- meta analyses
- drug administration